Login to Your Account

States doing the heavy lifting on FDA off-label gag rules

By Mari Serebrov
Regulatory Editor

Friday, January 12, 2018

States are taking action to either sidestep the FDA or force it to rethink its regulations that keep drug and device companies from sharing truthful, scientific information about off-label uses of their products.

Arizona led the pack last year when it became the first state in the U.S. to enact legislation safeguarding manufacturers' rights to share truthful research and information about off-label use of FDA-approved products. The bipartisan bill passed both the Arizona House and Senate unanimously.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription